Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.20%
1,108.23
-2.24
-0.20%
—1,110.471,107.751,111.341,093.81——
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
605.63
+1.56
+0.26%
—604.07604.07606.04600.91——
SIXE
Energy
SIXE
Energy
SIXE
+0.70%
1,209.95
+8.46
+0.70%
—1,201.491,205.921,215.311,201.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.40%
1,758.23
-7.07
-0.40%
—1,765.301,764.031,764.031,736.40——
SIXM
Financials
SIXM
Financials
SIXM
+0.72%
634.94
+4.52
+0.72%
—630.42630.34636.69626.03——
SIXR
Staples
SIXR
Staples
SIXR
+1.30%
852.37
+10.92
+1.30%
—841.45843.60858.11840.11——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.01%
218.85
+0.020
+0.01%
—218.83218.83219.32217.33——
SIXT
Technology
SIXT
Technology
SIXT
-1.50%
3,528.49
-53.74
-1.50%
—3,582.233,550.603,562.623,447.78——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
914.82
+0.93
+0.10%
—913.89912.75918.12906.67——
SIXV
Health care
SIXV
Health care
SIXV
+1.93%
1,472.27
+27.94
+1.93%
—1,444.331,446.871,480.741,446.30——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.93%
2,390.61
-22.35
-0.93%
—2,412.962,403.992,411.412,373.90——
Q4 2026 earnings • released • Revenue miss -1.67%
See results
4568:TYO
Daiichi Sankyo Co Ltd
¥2,725.50
-0.46%
(-12.50) 1D
May 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4568...
Open
¥2,736
High
¥2,746
Low
¥2,674
Mkt. cap
5.16T
Avg. vol.
9.21M
Volume
7.06M
Dividend
2.53%
Quarterly dividend
¥17
P/E ratio
19.42
52-wk high
¥4,178
52-wk low
¥2,443
EPS
¥140
Shares outstanding
647.77M
No. of employees
20K
News stories
From sources across the web
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees19.8K
FoundedSep 28, 2005
HeadquartersChuo City, Tokyo, Japan
Sector-
Websitedaiichisankyo.co.jp
Last report
May 11, 2026
Fiscal Period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
589.59B / 599.57B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
474.60B
500.76B
558.11B
589.59B
Cost of goods sold
92.35B
155.98B
118.28B
302.44B
Cost of revenue
92.35B
155.98B
118.28B
302.44B
Research and development expenses
105.95B
111.72B
122.11B
126.23B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
180.35B
189.08B
228.23B
183.02B
Operating expense
285.54B
297.25B
350.29B
291.83B
Total operating expenses
377.88B
453.23B
468.57B
594.27B
Operating income
96.71B
47.52B
89.54B
-4.69B
Other non operating income
-1.00M
-
-
2.00M
EBT including unusual items
105.44B
57.78B
106.73B
-6.52B
EBT excluding unusual items
105.44B
57.78B
106.73B
-6.52B
Income tax expense
19.94B
12.46B
20.10B
-48.94B
Effective tax rate
18.91%
21.57%
18.83%
751.04%
Other operating expenses
-760.00M
-3.56B
-49.00M
-17.41B
Net income
85.50B
45.31B
86.63B
42.43B
Net profit margin
18.02%
9.05%
15.52%
7.20%
Earnings per share
-
-
-
-
Interest and investment income
9.78B
10.68B
19.08B
1.28B
Interest expense
-1.42B
-834.00M
-2.16B
-3.57B
Net interest expenses
8.36B
9.84B
16.91B
-2.28B
Depreciation and amortization charges
-
-
-
-
EBITDA
114.51B
66.41B
109.18B
16.44B
Gain or loss from assets sale
199.00M
1.75B
573.00M
8.50B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer